S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   298.90 (+0.88%)
AAPL   116.45 (+0.36%)
MSFT   215.19 (+0.62%)
FB   277.66 (+0.75%)
GOOGL   1,785.94 (+1.24%)
AMZN   3,197.04 (+0.38%)
TSLA   585.97 (+2.09%)
NVDA   530.10 (+0.13%)
BABA   276.76 (-0.35%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.18 (+0.54%)
T   29.03 (+0.14%)
NIO   54.16 (+0.88%)
F   9.10 (+0.22%)
ACB   10.55 (+21.13%)
NFLX   491.36 (+1.31%)
BA   216.66 (-0.44%)
GILD   59.99 (+0.82%)
DIS   147.01 (-1.40%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   298.90 (+0.88%)
AAPL   116.45 (+0.36%)
MSFT   215.19 (+0.62%)
FB   277.66 (+0.75%)
GOOGL   1,785.94 (+1.24%)
AMZN   3,197.04 (+0.38%)
TSLA   585.97 (+2.09%)
NVDA   530.10 (+0.13%)
BABA   276.76 (-0.35%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.18 (+0.54%)
T   29.03 (+0.14%)
NIO   54.16 (+0.88%)
F   9.10 (+0.22%)
ACB   10.55 (+21.13%)
NFLX   491.36 (+1.31%)
BA   216.66 (-0.44%)
GILD   59.99 (+0.82%)
DIS   147.01 (-1.40%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   298.90 (+0.88%)
AAPL   116.45 (+0.36%)
MSFT   215.19 (+0.62%)
FB   277.66 (+0.75%)
GOOGL   1,785.94 (+1.24%)
AMZN   3,197.04 (+0.38%)
TSLA   585.97 (+2.09%)
NVDA   530.10 (+0.13%)
BABA   276.76 (-0.35%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.18 (+0.54%)
T   29.03 (+0.14%)
NIO   54.16 (+0.88%)
F   9.10 (+0.22%)
ACB   10.55 (+21.13%)
NFLX   491.36 (+1.31%)
BA   216.66 (-0.44%)
GILD   59.99 (+0.82%)
DIS   147.01 (-1.40%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   298.90 (+0.88%)
AAPL   116.45 (+0.36%)
MSFT   215.19 (+0.62%)
FB   277.66 (+0.75%)
GOOGL   1,785.94 (+1.24%)
AMZN   3,197.04 (+0.38%)
TSLA   585.97 (+2.09%)
NVDA   530.10 (+0.13%)
BABA   276.76 (-0.35%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.18 (+0.54%)
T   29.03 (+0.14%)
NIO   54.16 (+0.88%)
F   9.10 (+0.22%)
ACB   10.55 (+21.13%)
NFLX   491.36 (+1.31%)
BA   216.66 (-0.44%)
GILD   59.99 (+0.82%)
DIS   147.01 (-1.40%)
Log in
OTCMKTS:KMPH

KemPharm Short Interest Ratio and Short Volume

$1.10
-0.02 (-2.05 %)
(As of 11/25/2020 03:59 PM ET)
Add
Compare
Today's Range
$1.03
Now: $1.10
$1.26
50-Day Range
$0.50
MA: $0.66
$1.12
52-Week Range
$0.12
Now: $1.10
$1.38
Volume1.03 million shs
Average Volume1.73 million shs
Market Capitalization$79.58 million
P/E RatioN/A
Dividend YieldN/A
Beta2.68

Short Interest

KemPharm (OTCMKTS:KMPH) Short Interest Data

Current Short Volume:132,000 shares
Previous Short Volume:50,700 shares
Change Vs. Previous Month:+160.36%
Dollar Volume Sold Short:$79,200.00
Short Interest Ratio / Days to Cover:0.0
Last Record Date:October, 30 2020
Outstanding Shares:28,520,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:1,025,126 shares
Average Trading Volume:1,729,664 shares
Today's Volume Vs. Average:-40.73%



KemPharm (OTCMKTS:KMPH) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
10/30/2020132,000 $79,200.00 160.4%0.0%0.2$0.60
10/15/202050,700 $30,420.00 -7.8%0.0%0.1$0.60
9/30/202055,000 $0.00 -21.8%0.0%0.1$0.00
9/15/202070,300 $49,210.00 7.8%0.0%0.1$0.70

KemPharm (OTCMKTS:KMPH) Short Interest FAQ

speech bubbles
speech bubbles











What is KemPharm's current short interest?

Short interest is the volume of KemPharm shares that have been sold short but have not yet been covered or closed out. As of October 30th, traders have sold 132,000 shares of KMPH short. 0.00% of KemPharm's shares are currently sold short. View details.

Is KemPharm's short interest increasing or decreasing?

KemPharm saw a increase in short interest in the month of October. As of October 30th, there was short interest totaling 132,000 shares, an increase of 160.4% from the previous total of 50,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does KemPharm's short interest compare to its competitors?

0.00% of KemPharm's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to KemPharm: RedHill Biopharma Ltd. (0.00%), BeyondSpring Inc. (6.29%), Fulcrum Therapeutics, Inc. (9.71%), Altimmune, Inc. (0.00%), Arbutus Biopharma Co. (0.00%), Osmotica Pharmaceuticals plc (7.99%), Kamada Ltd. (1.91%), Verastem, Inc. (0.00%), Summit Therapeutics Inc. (0.24%), and OrganiGram Holdings Inc. (7.60%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.66 billion), Aon Plc ($3.83 billion), Analog Devices, Inc. ($3.33 billion), ViacomCBS Inc. ($3.13 billion), Snap Inc. ($3.05 billion), The Clorox Company ($2.85 billion), Uber Technologies, Inc. ($2.80 billion), Moderna, Inc. ($2.26 billion), Simon Property Group, Inc. ($2.02 billion), and International Flavors & Fragrances Inc. ($1.96 billion). View all of the most shorted stocks.

What does it mean to sell short KemPharm stock?

Short selling KMPH is an investing strategy that aims to generate trading profit from KemPharm as its price is falling. KemPharm's stock is trading down $0.02 today. To short KemPharm stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that KemPharm will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against KemPharm?

A short squeeze for KemPharm occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KMPH, which in turn drives the price of the stock up even further.

How often is KemPharm's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KMPH, twice per month. The most recent reporting period available is October, 30 2020.


This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.